Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 1997The Journal of Infectious DiseasesOpen Access

A Randomized Trial (ISS 902) of Didanosine versus Zidovudine in Previously Untreated Patients with Mildly Symptomatic Human Immunodeficiency Virus Infection

View Full Paper
Ask AI
Bookmark
Share

Authors

MFMarco FloridiaIstituto Superiore di SanitàSVStefano VellaUniversità Cattolica del Sacro CuoreASAngela Claudia Seeber

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Floridia et al. (1997) studied this question.

synapsesocial.com/papers/6a20808927dc97a0e8cd4128https://doi.org/10.1093/infdis/175.2.255
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Changes in drug sensitivity of human immunodeficiency virus type 1 during therapy with azidothymidine, dideoxycytidine, and dideoxyinosine: an in vitro comparative study.1993 · 132 citations
  2. 2The Safety and Efficacy of Zidovudine (AZT) in the Treatment of Subjects with Mildly Symptomatic Human Immunodeficiency Virus Type 1 (HIV) Infection1990 · 606 citations
  3. 3The Effects on Survival of Early Treatment of Human Immunodeficiency Virus Infection1992 · 216 citations
  4. 4The Duration of Zidovudine Benefit in Persons With Asymptomatic HIV Infection1994 · 116 citations
  5. 5Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection1990 · 1,288 citations